Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: 2021-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
74,572,235
Percent of class
13.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-021765
Form type
SC 13G/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Feb 14, 2022
Reporting period
Dec 31, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub